China Approves Obesity Drug for Severe Fatty Liver Disease

The approval follows increased competition among pharmaceutical companies pushing to attain weight-loss medication approval to treat a wider range of illnesses.

NewsBeagle is a discovery engine. We show the headline, a short source-supplied summary and clear attribution. The complete reporting remains with the publisher.